Trial of Orencia in Patients With Myasthenia Gravis

Summary

This pilot research study is being done to see if the drug abatacept (Orencia ®) will be helpful in treating patients with myasthenia gravis (MG) who do not respond satisfactorily to other drugs that are used to suppress the immune system. Abatacept has been successful in treating experimental MG in laboratory animals, and this study is to determine its effectiveness in patients with MG.

Timeline

Start

2017-04-12

Primary completion

2019-07-15

Completion

2019-07-15

Outcome

Outcome not reported

Stopped: “Mutual decision of sponsor and investigator due to logistical challenges”

Drugs

Indications